APIChangelogInfo
Common stock only
S&P 500 only
Director Only
10% Owner Only

Trans Codes

Select...
Amount
-
Stock
Insider transactions
SCHOLAR ROCK HOLDING
tastytradeTrade SRRK
SRRK Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►PriceVolumeJul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '2501224364860720800k1 600k2 400k3 200k4 000k4 800k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-05-29
2025-05-30
BUROW KRISTINA
S - Sale
Common Stock
-5,400
$30.00
-162K
2
$593.84M
2025-05-29
2025-05-30
BRUDNICK RICHARD
S - Sale
Common Stock
-6,075
$30.00
-182K
2
$593.84M
2025-05-29
2025-05-30
FLIER JEFFREY
S - Sale
Common Stock
-6,075
$30.00
-182K
2
$593.84M
2025-05-29
2025-05-30
VAISHNAW AKSHAY
President of R&D
S - Sale
Common Stock
-6,750
$30.00
-203K
2
$593.84M
2025-05-29
2025-05-30
GILMAN MICHAEL
S - Sale
Common Stock
-3,375
$30.00
-101K
2
$593.84M
2025-05-29
2025-05-30
REED JOSHUA
S - Sale
Common Stock
-5,400
$30.00
-162K
2
$593.84M
2025-05-29
2025-05-29
FLIER JEFFREY
S - Sale
-48,663
$30.00
-1.46M
1
$593.84M
2025-05-22
2025-05-23
FLIER JEFFREY
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
FLIER JEFFREY
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
GILMAN MICHAEL
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
PENG KATIE
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
PENG KATIE
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
REED JOSHUA
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
REED JOSHUA
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
AKKARAJU SRINIVAS
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
AKKARAJU SRINIVAS
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
BRUDNICK RICHARD
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
BRUDNICK RICHARD
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
BUROW KRISTINA
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
BUROW KRISTINA
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
FLIER JEFFREY
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
FLIER JEFFREY
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
GILMAN MICHAEL
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
GILMAN MICHAEL
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
PENG KATIE
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
PENG KATIE
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
REED JOSHUA
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
REED JOSHUA
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
GILMAN MICHAEL
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
AKKARAJU SRINIVAS
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
AKKARAJU SRINIVAS
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
BRUDNICK RICHARD
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
BRUDNICK RICHARD
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-22
2025-05-23
BUROW KRISTINA
A - Grant
Stock Option (Right to Buy)
9,206
$0.00
1
$593.84M
2025-05-22
2025-05-23
BUROW KRISTINA
A - Grant
Common Stock
7,632
$0.00
1
$593.84M
2025-05-02
2025-05-06
SINHA VIKAS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
110K
$0.00
1
$593.84M
2025-05-02
2025-05-06
VAISHNAW AKSHAY
President of R&D
A - Grant
Stock Option (Right to Buy)
110K
$0.00
1
$593.84M
2025-05-02
2025-05-06
WOODS KEITH
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
110K
$0.00
1
$593.84M
2025-05-02
2025-05-06
HALLAL DAVID
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
275K
$0.00
1
$593.84M
2025-04-27
2025-04-29
HALLAL DAVID
CEO
A - Grant
Common Stock
1.50M
$0.00
2
$593.84M
2025-04-27
2025-04-29
SINHA VIKAS
Chief Financial Officer
A - Grant
Common Stock
600K
$0.00
2
$593.84M
2025-04-27
2025-04-29
VAISHNAW AKSHAY
President of R&D
A - Grant
Common Stock
600K
$0.00
2
$593.84M
2025-04-27
2025-04-29
WOODS KEITH
Chief Operating Officer
A - Grant
Common Stock
600K
$0.00
2
$593.84M
2025-04-25
2025-04-29
SACCO TRACEY
Chief Commercial Officer
M - Exercise
Common Stock
5,000
$10.00
50,000
1
$593.84M
2025-04-25
2025-04-29
SACCO TRACEY
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$593.84M
2025-04-25
2025-04-29
SACCO TRACEY
Chief Commercial Officer
S - Sale
Common Stock
-5,000
$33.00
-165K
2
$593.84M
2025-03-24
2025-03-25
SACCO TRACEY
Chief Commercial Officer
S - Sale
Common Stock
-6,500
$33.00
-215K
2
$593.84M
2025-03-24
2025-03-25
MOORE ERIN
Interim PFO and PAO
M - Exercise
Stock Option (Right to Buy)
-13,564
$0.00
2
$593.84M
2025-03-24
2025-03-25
MOORE ERIN
Interim PFO and PAO
M - Exercise
Common Stock
13,564
$17.00
231K
2
$593.84M
2025-03-24
2025-03-25
SACCO TRACEY
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$593.84M
2025-03-24
2025-03-25
SACCO TRACEY
Chief Commercial Officer
M - Exercise
Common Stock
5,000
$10.00
50,000
1
$593.84M
2025-03-24
2025-03-25
MOORE ERIN
Interim PFO and PAO
S - Sale
Common Stock
-13,564
$33.00
-448K
1
$593.84M
2025-03-24
2025-03-25
SACCO TRACEY
Chief Commercial Officer
S - Sale
Common Stock
-6,500
$33.00
-215K
2
$593.84M
2025-03-24
2025-03-25
SACCO TRACEY
Chief Commercial Officer
S - Sale
Common Stock
-6,500
$33.00
-215K
2
$593.84M
2025-03-24
2025-03-25
MOORE ERIN
Interim PFO and PAO
M - Exercise
Stock Option (Right to Buy)
-13,564
$0.00
2
$593.84M
2025-03-24
2025-03-25
MOORE ERIN
Interim PFO and PAO
M - Exercise
Common Stock
13,564
$17.00
231K
2
$593.84M
2025-03-24
2025-03-25
SACCO TRACEY
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$593.84M
2025-03-24
2025-03-25
SACCO TRACEY
Chief Commercial Officer
M - Exercise
Common Stock
5,000
$10.00
50,000
1
$593.84M
2025-03-24
2025-03-25
MOORE ERIN
Interim PFO and PAO
S - Sale
Common Stock
-13,564
$33.00
-448K
1
$593.84M
2025-03-24
2025-03-25
MOORE ERIN
Interim PFO and PAO
M - Exercise
Stock Option (Right to Buy)
-13,564
$0.00
2
$593.84M
2025-03-24
2025-03-25
MOORE ERIN
Interim PFO and PAO
M - Exercise
Common Stock
13,564
$17.00
231K
2
$593.84M
2025-03-24
2025-03-25
SACCO TRACEY
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$593.84M
2025-03-24
2025-03-25
SACCO TRACEY
Chief Commercial Officer
M - Exercise
Common Stock
5,000
$10.00
50,000
1
$593.84M
2025-03-24
2025-03-25
MOORE ERIN
Interim PFO and PAO
S - Sale
Common Stock
-13,564
$33.00
-448K
1
$593.84M
2025-03-24
2025-03-24
SACCO TRACEY
Chief Commercial Officer
S - Sale
-41,500
$33.00
-1.37M
1
$593.84M
2025-03-17
2025-03-19
PENG KATIE
S - Sale
Common Stock
-1,006
$34.00
-34,204
1
$593.84M
2025-03-17
2025-03-17
PENG KATIE
S - Sale
-4,037
$35.00
-141K
1
$593.84M
2025-03-10
2025-03-12
MYLES EDWARD
COO & CFO
M - Exercise
Common Stock
113K
$14.00
1.58M
5
$593.84M
2025-03-10
2025-03-12
BACKSTROM JAY
CHIEF EXECUTIVE OFFICER
A - Grant
Stock Option (Right to Buy)
151K
$0.00
1
$593.84M
2025-03-10
2025-03-12
BACKSTROM JAY
CHIEF EXECUTIVE OFFICER
A - Grant
Common Stock
114K
$0.00
1
$593.84M
2025-03-10
2025-03-12
HO JUNLIN
GENERAL COUNSEL
A - Grant
Stock Option (Right to Buy)
42,855
$0.00
1
$593.84M
2025-03-10
2025-03-12
HO JUNLIN
GENERAL COUNSEL
A - Grant
Common Stock
32,145
$0.00
1
$593.84M
2025-03-10
2025-03-12
MARANTZ JING
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
45,715
$0.00
1
$593.84M
2025-03-10
2025-03-12
MARANTZ JING
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
34,285
$0.00
1
$593.84M
2025-03-10
2025-03-12
PARLAVECCHIO CARYN
CHRO
A - Grant
Stock Option (Right to Buy)
31,430
$0.00
1
$593.84M
2025-03-10
2025-03-12
PARLAVECCHIO CARYN
CHRO
A - Grant
Common Stock
23,570
$0.00
1
$593.84M
2025-03-10
2025-03-12
QATANANI MO
CHIEF SCIENTIFIC OFFICER
A - Grant
Stock Option (Right to Buy)
42,855
$0.00
1
$593.84M
2025-03-10
2025-03-12
QATANANI MO
CHIEF SCIENTIFIC OFFICER
A - Grant
Common Stock
32,145
$0.00
1
$593.84M
2025-03-10
2025-03-12
SACCO TRACEY
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
37,145
$0.00
1
$593.84M
2025-03-10
2025-03-12
SACCO TRACEY
Chief Commercial Officer
A - Grant
Common Stock
27,855
$0.00
1
$593.84M
2025-03-10
2025-03-12
MYLES EDWARD
COO & CFO
M - Exercise
Stock Option (Right to Buy)
-113K
$0.00
5
$593.84M
2025-03-10
2025-03-12
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-142K
$36.00
-5.12M
2
$593.84M
2025-03-10
2025-03-10
MYLES EDWARD
COO & CFO
S - Sale
-162K
$35.00
-5.67M
1
$593.84M
2025-02-19
2025-02-20
QATANANI MO
CHIEF SCIENTIFIC OFFICER
M - Exercise
Stock Option (Right to Buy)
-48,308
$0.00
4
$593.84M
2025-02-19
2025-02-20
QATANANI MO
CHIEF SCIENTIFIC OFFICER
M - Exercise
Common Stock
48,308
$10.00
483K
4
$593.84M
2025-02-19
2025-02-20
QATANANI MO
CHIEF SCIENTIFIC OFFICER
S - Sale
Common Stock
-68,510
$37.00
-2.53M
3
$593.84M
2025-02-18
2025-02-20
BACKSTROM JAY
CHIEF EXECUTIVE OFFICER
S - Sale
Common Stock
-18,372
$37.00
-680K
1
$593.84M
2025-02-18
2025-02-20
HO JUNLIN
GENERAL COUNSEL
S - Sale
Common Stock
-5,742
$37.00
-212K
1
$593.84M
2025-02-18
2025-02-20
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-7,809
$37.00
-289K
1
$593.84M
2025-02-18
2025-02-20
PARLAVECCHIO CARYN
CHRO
S - Sale
Common Stock
-5,296
$37.00
-196K
1
$593.84M
2025-02-18
2025-02-20
QATANANI MO
CHIEF SCIENTIFIC OFFICER
S - Sale
Common Stock
-4,135
$37.00
-153K
1
$593.84M
2025-02-19
2025-02-19
MOHAMMED QATANANI
S - Sale
-68,510
$37.00
-2.53M
1
$593.84M
2025-01-16
2025-01-21
SACCO TRACEY
Chief Commercial Officer
S - Sale
Common Stock
-3,890
$44.00
-171K
1
$593.84M
2025-01-16
2025-01-21
BACKSTROM JAY
CHIEF EXECUTIVE OFFICER
S - Sale
Common Stock
-22,308
$44.00
-982K
1
$593.84M
2025-01-16
2025-01-21
HO JUNLIN
GENERAL COUNSEL
S - Sale
Common Stock
-9,039
$44.00
-398K
1
$593.84M
2025-01-16
2025-01-21
MARANTZ JING
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-5,655
$44.00
-249K
1
$593.84M
2025-01-16
2025-01-21
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-12,539
$44.00
-552K
1
$593.84M
2025-01-16
2025-01-21
PARLAVECCHIO CARYN
CHRO
S - Sale
Common Stock
-6,434
$44.00
-283K
1
$593.84M
2025-01-16
2025-01-21
QATANANI MO
CHIEF SCIENTIFIC OFFICER
S - Sale
Common Stock
-7,347
$44.00
-323K
1
$593.84M
2024-12-10
2024-12-12
INVUS PUBLIC EQUITIES, L.P.
S - Sale
Common Stock
-1.60M
$42.00
-67M
1
$593.84M
2024-11-25
2024-11-27
INVUS PUBLIC EQUITIES, L.P.
S - Sale
Common Stock
-409K
$38.00
-16M
5
$593.84M
2024-11-25
2024-11-26
MARANTZ JING
CHIEF MEDICAL OFFICER
M - Exercise
Stock Option (Right to Buy)
-6,375
$0.00
1
$593.84M
2024-11-25
2024-11-26
MARANTZ JING
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
6,375
$9.00
57,375
1
$593.84M
2024-11-25
2024-11-26
MARANTZ JING
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-6,375
$39.00
-249K
4
$593.84M
2024-11-22
2024-11-26
MARANTZ JING
CHIEF MEDICAL OFFICER
M - Exercise
Stock Option (Right to Buy)
-2,145
$0.00
1
$593.84M
2024-11-22
2024-11-26
MARANTZ JING
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
2,145
$9.00
19,305
1
$593.84M
2024-11-22
2024-11-26
MARANTZ JING
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-2,145
$30.00
-64,350
1
$593.84M
2024-11-12
2024-11-13
GILMAN MICHAEL
G - Gift
Common Stock
-37,459
1
$593.84M
2024-11-12
2024-11-13
GILMAN MICHAEL
G - Gift
Common Stock
37,459
1
$593.84M
2024-11-11
2024-11-13
MARANTZ JING
CHIEF MEDICAL OFFICER
M - Exercise
Stock Option (Right to Buy)
-2,105
$0.00
1
$593.84M
2024-11-11
2024-11-13
MARANTZ JING
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
2,105
$9.00
18,945
1
$593.84M
2024-11-11
2024-11-13
MARANTZ JING
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-2,105
$30.00
-63,150
1
$593.84M
2024-10-08
2024-10-10
MYLES EDWARD
COO & CFO
M - Exercise
Stock Option (Right to Buy)
-37,187
$0.00
1
$593.84M
2024-10-08
2024-10-10
MYLES EDWARD
COO & CFO
M - Exercise
Common Stock
37,187
$10.00
372K
1
$593.84M
2024-10-08
2024-10-10
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-37,187
$35.00
-1.30M
1
$593.84M
2024-10-07
2024-10-07
AKKARAJU SRINIVAS
S - Sale
Common Stock
-1.18M
$29.00
-34M
3
$593.84M
2024-10-07
2024-10-07
MARANTZ JING
CHIEF MEDICAL OFFICER
M - Exercise
Stock Option (Right to Buy)
-109K
$0.00
1
$593.84M
2024-10-07
2024-10-07
MARANTZ JING
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
109K
$9.00
984K
1
$593.84M
2024-10-07
2024-10-07
MYLES EDWARD
COO & CFO
M - Exercise
Stock Option (Right to Buy)
-166K
$0.00
1
$593.84M
2024-10-07
2024-10-07
MYLES EDWARD
COO & CFO
M - Exercise
Common Stock
-206K
$14.00
-2.89M
1
$593.84M
2024-10-07
2024-10-07
SACCO TRACEY
CHIEF COMMERCIAL OFFICER
M - Exercise
Stock Option (Right to Buy)
30,000
$0.00
1
$593.84M
2024-10-07
2024-10-07
SACCO TRACEY
CHIEF COMMERCIAL OFFICER
M - Exercise
Common Stock
30,000
$10.00
300K
1
$593.84M
2024-10-07
2024-10-07
MYLES EDWARD
COO & CFO
S - Sale
-243K
$33.00
-8.03M
1
$593.84M
2024-10-07
2024-10-07
MARANTZ JING
CHIEF MEDICAL OFFICER
S - Sale
-120K
$33.00
-3.96M
1
$593.84M
2024-10-07
2024-10-07
MARANTZ JING
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-109K
$27.00
-2.95M
3
$593.84M
2024-10-07
2024-10-07
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-206K
$27.00
-5.57M
4
$593.84M
2024-10-07
2024-10-07
SACCO TRACEY
CHIEF COMMERCIAL OFFICER
S - Sale
Common Stock
-30,000
$26.00
-780K
2
$593.84M
2024-09-16
2024-09-19
QATANANI MO
CHIEF SCIENTIFIC OFFICER
S - Sale
Common Stock
-1,936
$9.00
-17,424
1
$593.84M
2024-08-16
2024-08-19
PARLAVECCHIO CARYN
CHRO
S - Sale
Common Stock
-1,451
$9.00
-13,059
1
$593.84M
2024-06-27
2024-07-01
AKKARAJU SRINIVAS
A - Grant
Stock Option (Right to Buy)
18,000
$0.00
1
$593.84M
2024-06-27
2024-07-01
AKKARAJU SRINIVAS
A - Grant
Common Stock
13,500
$0.00
1
$593.84M
2024-06-27
2024-07-01
BRUDNICK RICHARD
A - Grant
Stock Option (Right to Buy)
18,000
$0.00
1
$593.84M
2024-06-27
2024-07-01
BRUDNICK RICHARD
A - Grant
Common Stock
13,500
$0.00
1
$593.84M
2024-06-27
2024-07-01
BUROW KRISTINA
A - Grant
Stock Option (Right to Buy)
18,000
$0.00
1
$593.84M
2024-06-27
2024-07-01
BUROW KRISTINA
A - Grant
Common Stock
13,500
$0.00
1
$593.84M
2024-06-27
2024-07-01
FLIER JEFFREY
A - Grant
Stock Option (Right to Buy)
18,000
$0.00
1
$593.84M
2024-06-27
2024-07-01
FLIER JEFFREY
A - Grant
Common Stock
13,500
$0.00
1
$593.84M
2024-06-27
2024-07-01
GILMAN MICHAEL
A - Grant
Stock Option (Right to Buy)
18,000
$0.00
1
$593.84M
2024-06-27
2024-07-01
GILMAN MICHAEL
A - Grant
Common Stock
13,500
$0.00
1
$593.84M
2024-06-27
2024-07-01
HALLAL DAVID
A - Grant
Stock Option (Right to Buy)
18,000
$0.00
1
$593.84M
2024-06-27
2024-07-01
HALLAL DAVID
A - Grant
Common Stock
13,500
$0.00
1
$593.84M
2024-06-27
2024-07-01
PENG KATIE
A - Grant
Stock Option (Right to Buy)
6,000
$0.00
1
$593.84M
2024-06-27
2024-07-01
PENG KATIE
A - Grant
Common Stock
4,500
$0.00
1
$593.84M
2024-06-27
2024-07-01
REED JOSHUA
A - Grant
Stock Option (Right to Buy)
18,000
$0.00
1
$593.84M
2024-06-27
2024-07-01
REED JOSHUA
A - Grant
Common Stock
13,500
$0.00
1
$593.84M
2024-06-27
2024-07-01
VAISHNAW AKSHAY
A - Grant
Stock Option (Right to Buy)
18,000
$0.00
1
$593.84M
2024-06-27
2024-07-01
VAISHNAW AKSHAY
A - Grant
Common Stock
13,500
$0.00
1
$593.84M
2024-06-17
2024-06-18
HO JUNLIN
GENERAL COUNSEL
S - Sale
Common Stock
-4,695
$9.00
-42,255
1
$593.84M
2024-06-17
2024-06-18
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-9,458
$9.00
-85,122
1
$593.84M
2024-06-17
2024-06-18
PARLAVECCHIO CARYN
CHRO
S - Sale
Common Stock
-4,305
$9.00
-38,745
1
$593.84M
2024-06-17
2024-06-18
QATANANI MO
CHIEF SCIENTIFIC OFFICER
S - Sale
Common Stock
-2,315
$9.00
-20,835
1
$593.84M
2024-05-09
2024-05-13
NASHAT AMIR
J - Other
Common Stock
112K
$0.00
5
$593.84M
2024-05-09
2024-05-13
NASHAT AMIR
J - Other
Common Stock
-599K
$0.00
4
$593.84M
2024-04-09
2024-04-11
PENG KATIE
A - Grant
Stock Option (Right to Buy)
35,767
$0.00
1
$593.84M
2024-04-09
2024-04-11
PENG KATIE
A - Grant
Common Stock
26,825
$0.00
1
$593.84M
2024-02-16
2024-02-21
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-4,744
$16.00
-75,904
1
$593.84M
2024-02-16
2024-02-20
BACKSTROM JAY
CHIEF EXECUTIVE OFFICER
S - Sale
Common Stock
-11,614
$16.00
-186K
1
$593.84M
2024-02-16
2024-02-20
HO JUNLIN
GENERAL COUNSEL
S - Sale
Common Stock
-3,489
$16.00
-55,824
1
$593.84M
2024-02-16
2024-02-20
PARLAVECCHIO CARYN
CHRO
S - Sale
Common Stock
-3,751
$16.00
-60,016
1
$593.84M
2024-02-16
2024-02-20
QATANANI MO
CHIEF SCIENTIFIC OFFICER
S - Sale
Common Stock
-2,512
$16.00
-40,192
1
$593.84M
2024-02-12
2024-02-13
MARANTZ JING
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
72,855
$0.00
1
$593.84M
2024-02-12
2024-02-13
BACKSTROM JAY
CHIEF EXECUTIVE OFFICER
A - Grant
Stock Option (Right to Buy)
286K
$0.00
1
$593.84M
2024-02-12
2024-02-13
BACKSTROM JAY
CHIEF EXECUTIVE OFFICER
A - Grant
Common Stock
214K
$0.00
1
$593.84M
2024-02-12
2024-02-13
HO JUNLIN
GENERAL COUNSEL
A - Grant
Stock Option (Right to Buy)
77,145
$0.00
1
$593.84M
2024-02-12
2024-02-13
HO JUNLIN
GENERAL COUNSEL
A - Grant
Common Stock
57,855
$0.00
1
$593.84M
2024-02-12
2024-02-13
MARANTZ JING
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
97,145
$0.00
1
$593.84M
2024-02-12
2024-02-13
MYLES EDWARD
COO & CFO
A - Grant
Stock Option (Right to Buy)
71,430
$0.00
1
$593.84M
2024-02-12
2024-02-13
MYLES EDWARD
COO & CFO
A - Grant
Common Stock
53,570
$0.00
1
$593.84M
2024-02-12
2024-02-13
PARLAVECCHIO CARYN
CHRO
A - Grant
Stock Option (Right to Buy)
62,855
$0.00
1
$593.84M
2024-02-12
2024-02-13
PARLAVECCHIO CARYN
CHRO
A - Grant
Common Stock
47,145
$0.00
1
$593.84M
2024-02-12
2024-02-13
QATANANI MO
CHIEF SCIENTIFIC OFFICER
A - Grant
Stock Option (Right to Buy)
94,285
$0.00
1
$593.84M
2024-02-12
2024-02-13
QATANANI MO
CHIEF SCIENTIFIC OFFICER
A - Grant
Common Stock
70,715
$0.00
1
$593.84M
2024-02-12
2024-02-13
SACCO TRACEY
CHIEF COMMERCIAL OFFICER
A - Grant
Stock Option (Right to Buy)
65,715
$0.00
1
$593.84M
2024-02-12
2024-02-13
SACCO TRACEY
CHIEF COMMERCIAL OFFICER
A - Grant
Common Stock
49,285
$0.00
1
$593.84M
2024-01-16
2024-01-18
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-6,634
$16.00
-106K
1
$593.84M
2024-01-16
2024-01-18
PARLAVECCHIO CARYN
CHRO
S - Sale
Common Stock
-2,849
$16.00
-45,584
1
$593.84M
2024-01-16
2024-01-18
HO JUNLIN
GENERAL COUNSEL
S - Sale
Common Stock
-4,186
$16.00
-66,976
1
$593.84M
2024-01-16
2024-01-18
QATANANI MO
SVP AND HEAD OF RESEARCH
S - Sale
Common Stock
-2,002
$16.00
-32,032
1
$593.84M
2023-12-29
2023-12-29
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-12,459
$19.00
-237K
2
$593.84M
2023-12-29
2023-12-29
MYLES EDWARD
COO & CFO
M - Exercise
Stock Option (Right to Buy)
-24,914
$0.00
1
$593.84M
2023-12-29
2023-12-29
MYLES EDWARD
COO & CFO
M - Exercise
Common Stock
12,459
$5.00
62,295
1
$593.84M
2023-12-27
2023-12-29
NASHAT AMIR
G - Gift
Common Stock
-21,333
$0.00
1
$593.84M
2023-12-21
2023-12-26
BUROW KRISTINA
J - Other
Common Stock
-292K
$0.00
1
$593.84M
2023-12-21
2023-12-26
BUROW KRISTINA
J - Other
Common Stock
5,339
$0.00
1
$593.84M
2023-12-14
2023-12-15
QATANANI MO
SVP AND HEAD OF RESEARCH
M - Exercise
Common Stock
8,437
$10.00
84,370
1
$593.84M
2023-12-14
2023-12-15
QATANANI MO
SVP AND HEAD OF RESEARCH
S - Sale
Common Stock
-24,662
$18.00
-444K
1
$593.84M
2023-12-14
2023-12-15
QATANANI MO
SVP AND HEAD OF RESEARCH
M - Exercise
Stock Option (Right to Buy)
-8,437
$0.00
1
$593.84M
2023-12-13
2023-12-15
NASHAT AMIR
J - Other
Common Stock
224K
$0.00
5
$593.84M
2023-12-13
2023-12-15
NASHAT AMIR
J - Other
Common Stock
-1.20M
$0.00
4
$593.84M
2023-12-07
2023-12-08
MYLES EDWARD
COO & CFO
M - Exercise
Stock Option (Right to Buy)
-24,914
$0.00
1
$593.84M
2023-12-07
2023-12-08
MYLES EDWARD
COO & CFO
M - Exercise
Common Stock
24,914
$5.00
125K
1
$593.84M
2023-12-07
2023-12-08
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-24,914
$18.00
-448K
1
$593.84M
2023-11-20
2023-11-22
NASHAT AMIR
J - Other
Common Stock
-599K
$0.00
4
$593.84M
2023-11-20
2023-11-22
NASHAT AMIR
J - Other
Common Stock
112K
$0.00
5
$593.84M
2023-11-02
2023-11-03
MYLES EDWARD
COO & CFO
S - Sale
Common Stock
-35,007
$13.00
-455K
1
$593.84M
2023-10-16
2023-10-18
AKKARAJU SRINIVAS
P - Purchase
Common Stock
2.19M
$7.00
15M
1
$593.84M
2023-10-16
2023-10-18
SAMSARA BIOCAPITAL GP, LLC
P - Purchase
Common Stock
2.19M
$7.00
15M
1
$593.84M
2023-10-12
2023-10-16
INVUS PUBLIC EQUITIES, L.P.
P - Purchase
Common Stock
2.20M
$7.00
15M
2
$593.84M
2023-09-18
2023-09-20
QATANANI MO
SVP AND HEAD OF RESEARCH
S - Sale
Common Stock
-1,945
$6.00
-11,670
1
$593.84M
2023-08-16
2023-08-18
PARLAVECCHIO CARYN
CHRO
S - Sale
Common Stock
-1,353
$7.00
-9,471
1
$593.84M
2023-06-21
2023-06-23
BUROW KRISTINA
A - Grant
Stock Option (Right to Buy)
36,000
$0.00
1
$593.84M
2023-06-21
2023-06-22
AKKARAJU SRINIVAS
A - Grant
Stock Option (Right to Buy)
36,000
$0.00
1
$593.84M
2023-06-21
2023-06-22
FLIER JEFFREY
A - Grant
Stock Option (Right to Buy)
36,000
$0.00
1
$593.84M
2023-06-21
2023-06-22
GILMAN MICHAEL
A - Grant
Stock Option (Right to Buy)
36,000
$0.00
1
$593.84M
2023-06-21
2023-06-22
HALLAL DAVID
A - Grant
Stock Option (Right to Buy)
36,000
$0.00
1
$593.84M
2023-06-21
2023-06-22
NASHAT AMIR
A - Grant
Stock Option (Right to Buy)
36,000
$0.00
1
$593.84M
2023-06-21
2023-06-22
REED JOSHUA
A - Grant
Stock Option (Right to Buy)
36,000
$0.00
1
$593.84M
2023-06-21
2023-06-22
VAISHNAW AKSHAY
A - Grant
Stock Option (Right to Buy)
36,000
$0.00
1
$593.84M
2023-06-21
2023-06-22
HO JUNLIN
GENERAL COUNSEL
F - Tax
Common Stock
-4,346
$9.00
-39,114
1
$593.84M
2023-06-21
2023-06-22
MYLES EDWARD
COO & CFO
F - Tax
Common Stock
-7,138
$9.00
-64,242
1
$593.84M
2023-06-21
2023-06-22
PARLAVECCHIO CARYN
CHRO
F - Tax
Common Stock
-4,038
$9.00
-36,342
1
$593.84M
2023-04-28
2023-05-02
INVUS PUBLIC EQUITIES, L.P.
P - Purchase
Common Stock
31,557
$6.00
189K
1
$593.84M
2023-04-06
2023-04-10
BRUDNICK RICHARD
A - Grant
Stock Option (Right to Buy)
56,000
$0.00
1
$593.84M
2023-02-13
2023-02-15
BACKSTROM JAY
CHIEF EXECUTIVE OFFICER
A - Grant
Common Stock
150K
$0.00
1
$593.84M
2023-02-13
2023-02-15
BACKSTROM JAY
CHIEF EXECUTIVE OFFICER
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$593.84M
2023-02-13
2023-02-15
HO JUNLIN
GENERAL COUNSEL
A - Grant
Stock Option (Right to Buy)
62,500
$0.00
1
$593.84M
2023-02-13
2023-02-15
HO JUNLIN
GENERAL COUNSEL
A - Grant
Common Stock
46,875
$0.00
1
$593.84M
2023-02-13
2023-02-15
MYLES EDWARD
COO & CFO
A - Grant
Stock Option (Right to Buy)
85,000
$0.00
1
$593.84M
2023-02-13
2023-02-15
MYLES EDWARD
COO & CFO
A - Grant
Common Stock
63,750
$0.00
1
$593.84M
2023-02-13
2023-02-15
PARLAVECCHIO CARYN
CHRO
A - Grant
Stock Option (Right to Buy)
62,500
$0.00
1
$593.84M
2023-02-13
2023-02-15
PARLAVECCHIO CARYN
CHRO
A - Grant
Common Stock
46,875
$0.00
1
$593.84M
2023-01-17
2023-01-19
MYLES EDWARD
COO & CFO
F - Tax
Common Stock
-7,043
$11.00
-77,473
1
$593.84M
2023-01-17
2023-01-19
HO JUNLIN
GENERAL COUNSEL
F - Tax
Common Stock
-4,529
$11.00
-49,819
1
$593.84M
2023-01-17
2023-01-19
PARLAVECCHIO CARYN
CHRO
F - Tax
Common Stock
-2,934
$11.00
-32,274
1
$593.84M
2023-01-09
2023-01-11
INVUS PUBLIC EQUITIES, L.P.
S - Sale
Common Stock
-1,094
$9.00
-9,846
1
$593.84M
2023-01-05
2023-01-09
INVUS PUBLIC EQUITIES, L.P.
P - Purchase
Common Stock
48,774
$9.00
439K
1
$593.84M
2022-11-14
2022-11-15
MARANTZ JING
Chief Medical Officer
A - Grant
Stock Option (right to buy)
250K
$0.00
1
$593.84M
2022-10-25
2022-10-27
INVUS PUBLIC EQUITIES, L.P.
P - Purchase
Common Stock
130K
$8.00
1.04M
1
$593.84M
2022-10-04
2022-10-07
INVUS PUBLIC EQUITIES, L.P.
P - Purchase
Common Stock
66,000
$8.00
528K
1
$593.84M
2022-10-03
2022-10-07
INVUS PUBLIC EQUITIES, L.P.
P - Purchase
Common Stock
33,971
$7.00
238K
1
$593.84M
2022-09-20
2022-09-22
BACKSTROM JAY
CEO-Elect
A - Grant
Stock Option (right to buy)
1.00M
$0.00
1
$593.84M
2022-09-16
2022-09-20
AKKARAJU SRINIVAS
A - Grant
Stock Option (Right to Buy)
56,000
$0.00
1
$593.84M
2022-08-16
2022-08-17
PARLAVECCHIO CARYN
CHRO
F - Tax
Common Stock
-1,401
$11.00
-15,411
1
$593.84M
2022-07-08
2022-07-12
GILMAN MICHAEL
G - Gift
Common Stock
37,459
1
$593.84M
2022-07-08
2022-07-12
GILMAN MICHAEL
G - Gift
Common Stock
-37,459
1
$593.84M
2022-06-22
2022-06-24
NASHAT AMIR
P - Purchase
Common Warrant (right to buy)
299K
$5.00
1.50M
2
$593.84M
2022-06-22
2022-06-24
NASHAT AMIR
P - Purchase
Common Stock
1.20M
$5.00
5.99M
2
$593.84M
2022-06-16
2022-06-21
CARVEN GREGORY JOHN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
45,500
$0.00
1
$593.84M
2022-06-16
2022-06-21
CARVEN GREGORY JOHN
Chief Scientific Officer
A - Grant
Common Stock
45,500
$0.00
1
$593.84M
2022-06-16
2022-06-21
GILMAN MICHAEL
A - Grant
Stock Option (Right to Buy)
14,000
$0.00
1
$593.84M
2022-06-16
2022-06-21
HALLAL DAVID
A - Grant
Stock Option (Right to Buy)
14,000
$0.00
1
$593.84M
2022-06-16
2022-06-21
HO JUNLIN
General Counsel
A - Grant
Stock Option (Right to Buy)
45,500
$0.00
1
$593.84M
2022-06-16
2022-06-21
HO JUNLIN
General Counsel
A - Grant
Common Stock
45,500
$0.00
1
$593.84M
2022-06-16
2022-06-21
MAHANTHAPPA NAGESH
Interim CEO and President
A - Grant
Stock Option (Right to Buy)
50,000
$0.00
1
$593.84M
2022-06-16
2022-06-21
MAHANTHAPPA NAGESH
Interim CEO and President
A - Grant
Common Stock
50,000
$0.00
1
$593.84M
2022-06-16
2022-06-21
MYLES EDWARD
COO & CFO
A - Grant
Stock Option (Right to Buy)
74,750
$0.00
1
$593.84M
2022-06-16
2022-06-21
MYLES EDWARD
COO & CFO
A - Grant
Common Stock
74,750
$0.00
1
$593.84M
2022-06-16
2022-06-21
PARLAVECCHIO CARYN
CHRO
A - Grant
Stock Option (Right to Buy)
35,750
$0.00
1
$593.84M
2022-06-16
2022-06-21
PARLAVECCHIO CARYN
CHRO
A - Grant
Common Stock
35,750
$0.00
1
$593.84M
2022-06-16
2022-06-21
VAISHNAW AKSHAY
A - Grant
Stock Option (Right to Buy)
14,000
$0.00
1
$593.84M
2022-05-26
2022-05-27
GILMAN MICHAEL
A - Grant
Stock Option (Right to Buy)
28,000
$0.00
1
$593.84M
2022-05-26
2022-05-27
BUROW KRISTINA
A - Grant
Stock Option (Right to Buy)
28,000
$0.00
1
$593.84M
2022-05-26
2022-05-27
FLIER JEFFREY
A - Grant
Stock Option (Right to Buy)
28,000
$0.00
1
$593.84M
2022-05-26
2022-05-27
HALLAL DAVID
A - Grant
Stock Option (Right to Buy)
28,000
$0.00
1
$593.84M
2022-05-26
2022-05-27
NASHAT AMIR
A - Grant
Stock Option (Right to Buy)
28,000
$0.00
1
$593.84M
2022-05-26
2022-05-27
REED JOSHUA
A - Grant
Stock Option (Right to Buy)
28,000
$0.00
1
$593.84M
2022-05-26
2022-05-27
VAISHNAW AKSHAY
A - Grant
Stock Option (Right to Buy)
28,000
$0.00
1
$593.84M
2022-02-14
2022-02-15
CARVEN GREGORY JOHN
Chief Scientific Officer
A - Grant
Common Stock
35,000
$0.00
1
$593.84M
2022-02-14
2022-02-15
CHYUNG YUNG
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
37,500
$0.00
1
$593.84M
2022-02-14
2022-02-15
CARVEN GREGORY JOHN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
35,000
$0.00
1
$593.84M
2022-02-14
2022-02-15
CHYUNG YUNG
Chief Medical Officer
A - Grant
Common Stock
37,500
$0.00
1
$593.84M
2022-02-14
2022-02-15
HO JUNLIN
General Counsel
A - Grant
Stock Option (Right to Buy)
37,500
$0.00
1
$593.84M
2022-02-14
2022-02-15
HO JUNLIN
General Counsel
A - Grant
Common Stock
37,500
$0.00
1
$593.84M
2022-02-14
2022-02-15
MAHANTHAPPA NAGESH
Interim CEO and President
A - Grant
Stock Option (Right to Buy)
50,000
$0.00
1
$593.84M
2022-02-14
2022-02-15
MAHANTHAPPA NAGESH
Interim CEO and President
A - Grant
Common Stock
50,000
$0.00
1
$593.84M
2022-02-14
2022-02-15
MYLES EDWARD
COO & CFO
A - Grant
Stock Option (Right to Buy)
57,500
$0.00
1
$593.84M
2022-02-14
2022-02-15
MYLES EDWARD
COO & CFO
A - Grant
Common Stock
57,500
$0.00
1
$593.84M
2022-01-18
2022-01-19
CARVEN GREGORY JOHN
Chief Scientific Officer
F - Tax
Common Stock
-1,137
$19.00
-21,603
1
$593.84M
2022-01-18
2022-01-19
CHYUNG YUNG
Chief Medical Officer
F - Tax
Common Stock
-1,421
$19.00
-26,999
1
$593.84M
2022-01-18
2022-01-19
HO JUNLIN
General Counsel
F - Tax
Common Stock
-1,042
$19.00
-19,798
1
$593.84M
2022-01-18
2022-01-19
MYLES EDWARD
Chief Financial Officer
F - Tax
Common Stock
-2,178
$19.00
-41,382
1
$593.84M
2021-11-17
2021-11-19
NASHAT AMIR
J - Other
Common Stock
63,450
$0.00
5
$593.84M
2021-11-17
2021-11-19
NASHAT AMIR
J - Other
Common Stock
-339K
$0.00
4
$593.84M
2021-11-15
2021-11-15
MYLES EDWARD
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-4,879
$0.00
1
$593.84M
2021-11-15
2021-11-15
MYLES EDWARD
Chief Financial Officer
S - Sale
Common Stock
-4,879
$35.00
-171K
1
$593.84M
2021-11-15
2021-11-15
MYLES EDWARD
Chief Financial Officer
X - Exercise
Common Stock
4,879
1
$593.84M
2021-11-12
2021-11-15
MYLES EDWARD
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy
-2,351
$0.00
1
$593.84M
2021-11-12
2021-11-15
MYLES EDWARD
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-47,497
$0.00
1
$593.84M
2021-11-12
2021-11-15
MYLES EDWARD
Chief Financial Officer
S - Sale
Common Stock
-49,848
$35.00
-1.74M
1
$593.84M
2021-11-12
2021-11-15
MYLES EDWARD
Chief Financial Officer
X - Exercise
Common Stock
49,848
1
$593.84M
2021-11-11
2021-11-15
MYLES EDWARD
Chief Financial Officer
X - Exercise
Common Stock
23,574
1
$593.84M
2021-11-11
2021-11-15
MYLES EDWARD
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-23,574
$0.00
3
$593.84M
2021-11-11
2021-11-15
MYLES EDWARD
Chief Financial Officer
S - Sale
Common Stock
-23,574
$35.00
-825K
1
$593.84M
2021-10-01
2021-10-05
FLIER JEFFREY
S - Sale
Common Stock
-6,000
$31.00
-186K
1
$593.84M
2021-09-20
2021-09-21
FLIER JEFFREY
S - Sale
Common Stock
-500
$34.00
-17,000
1
$593.84M
2021-07-26
2021-07-28
FLIER JEFFREY
S - Sale
Common Stock
-6,000
$32.00
-192K
2
$593.84M
2021-05-27
2021-06-01
BUROW KRISTINA
A - Grant
Stock Option (Right to Buy)
7,800
$0.00
1
$593.84M
2021-05-27
2021-06-01
FLIER JEFFREY
A - Grant
Stock Option (Right to Buy)
7,800
$0.00
1
$593.84M
2021-05-27
2021-06-01
HALLAL DAVID
A - Grant
Stock Option (Right to Buy)
7,800
$0.00
1
$593.84M
2021-05-27
2021-06-01
NASHAT AMIR
A - Grant
Stock Option (Right to Buy)
7,800
$0.00
1
$593.84M
2021-05-27
2021-06-01
VAISHNAW AKSHAY
A - Grant
Stock Option (Right to Buy)
7,800
$0.00
1
$593.84M
2021-05-27
2021-06-01
GILMAN MICHAEL
D - Sale to Issuer
Stock Option (Right to Buy)
7,800
$0.00
1
$593.84M
2021-03-16
2021-03-18
REED JOSHUA
A - Grant
Stock Options (Right to Buy)
15,600
$0.00
1
$593.84M
2021-03-15
2021-03-17
GILMAN MICHAEL
S - Sale
Common Stock
-4,696
$66.00
-310K
1
$593.84M
2020-11-23
2021-02-16
FLIER JEFFREY
G - Gift
Common Stock
20,000
$0.00
1
$593.84M
2020-11-23
2021-02-16
FLIER JEFFREY
G - Gift
Common Stock
-20,000
$0.00
1
$593.84M
2021-02-08
2021-02-11
GILMAN MICHAEL
S - Sale
Common Stock
-1,804
$65.00
-117K
1
$593.84M
2021-02-01
2021-02-03
CARVEN GREGORY JOHN
Head of Research
A - Grant
Stock Option (Right to Buy)
42,000
$0.00
1
$593.84M
2021-02-01
2021-02-03
CARVEN GREGORY JOHN
Head of Research
A - Grant
Common Stock
12,600
$0.00
1
$593.84M
2021-02-01
2021-02-03
CHYUNG YUNG
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
52,500
$0.00
1
$593.84M
2021-02-01
2021-02-03
CHYUNG YUNG
Chief Medical Officer
A - Grant
Common Stock
15,750
$0.00
1
$593.84M
2021-02-01
2021-02-03
KINGSLEY STUART
President and CEO
A - Grant
Stock Option (Right to Buy)
140K
$0.00
1
$593.84M
2021-02-01
2021-02-03
KINGSLEY STUART
President and CEO
A - Grant
Common Stock
42,000
$0.00
1
$593.84M
2021-02-01
2021-02-03
MYLES EDWARD
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
80,500
$0.00
1
$593.84M
2021-02-01
2021-02-03
MYLES EDWARD
Chief Financial Officer
A - Grant
Common Stock
24,150
$0.00
1
$593.84M
2021-01-27
2021-01-28
CARVEN GREGORY JOHN
Head of Research
M - Exercise
Common Stock
6,619
$15.00
99,285
1
$593.84M
2021-01-27
2021-01-28
CARVEN GREGORY JOHN
Head of Research
M - Exercise
Stock Option (Right to Buy)
-6,619
$0.00
1
$593.84M
2021-01-27
2021-01-28
CARVEN GREGORY JOHN
Head of Research
S - Sale
Common Stock
-19,100
$57.00
-1.09M
3
$593.84M
2021-01-27
2021-01-28
CARVEN GREGORY JOHN
Head of Research
S - Sale
Common Stock
-19,100
$57.00
-1.09M
3
$593.84M
2021-01-26
2021-01-28
CARVEN GREGORY JOHN
Head of Research
S - Sale
Common Stock
-36,774
$59.00
-2.17M
5
$593.84M
2021-01-26
2021-01-28
CARVEN GREGORY JOHN
Head of Research
S - Sale
Common Stock
-3,607
$61.00
-220K
2
$593.84M
2021-01-26
2021-01-28
GILMAN MICHAEL
S - Sale
Common Stock
-3,501
$59.00
-207K
3
$593.84M
2021-01-26
2021-01-28
CARVEN GREGORY JOHN
Head of Research
M - Exercise
Stock Option (Right to Buy)
-30,900
$0.00
3
$593.84M
2021-01-26
2021-01-28
CARVEN GREGORY JOHN
Head of Research
M - Exercise
Common Stock
30,900
$9.00
278K
3
$593.84M
2021-01-26
2021-01-28
GILMAN MICHAEL
M - Exercise
Stock Option (Right to Buy)
-3,501
$0.00
2
$593.84M
2021-01-26
2021-01-28
GILMAN MICHAEL
M - Exercise
Common Stock
3,501
$6.00
21,006
2
$593.84M
2020-07-16
2020-07-17
KINGSLEY STUART
President and CEO
A - Grant
Stock Option (Right to Buy)
430K
$0.00
1
$593.84M
2020-07-16
2020-07-17
MYLES EDWARD
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$593.84M
2020-06-16
2020-06-18
BUROW KRISTINA
A - Grant
Stock Option (right to buy)
13,000
$0.00
1
$593.84M
2020-06-16
2020-06-18
FLIER JEFFREY
A - Grant
Stock Option (right to buy)
13,000
$0.00
1
$593.84M
2020-06-16
2020-06-18
GILMAN MICHAEL
A - Grant
Stock Option (right to buy)
13,000
$0.00
1
$593.84M
2020-06-16
2020-06-18
HALLAL DAVID
A - Grant
Stock Option (right to buy)
20,000
$0.00
2
$593.84M
2020-06-16
2020-06-18
MYLES EDWARD
A - Grant
Stock Option (right to buy)
13,000
$0.00
1
$593.84M
2020-06-16
2020-06-18
NASHAT AMIR
A - Grant
Stock Option (right to buy)
13,000
$0.00
1
$593.84M
2020-06-16
2020-06-18
VAISHNAW AKSHAY
A - Grant
Stock Option (right to buy)
13,000
$0.00
1
$593.84M
2020-05-20
2020-05-21
KINGSLEY STUART
A - Grant
Stock Option (right to buy)
20,316
$0.00
1
$593.84M
2020-02-06
2020-02-10
BUCKLER ALAN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$593.84M
2020-02-06
2020-02-10
MAHANTHAPPA NAGESH
President and CEO
A - Grant
Stock Option (Right to Buy)
164K
$0.00
1
$593.84M
2020-02-06
2020-02-10
CHYUNG YUNG
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$593.84M
2020-02-06
2020-02-10
MOORE ERIN
SVP, Finance
A - Grant
Stock Option (Right to Buy)
50,600
$0.00
1
$593.84M
2019-12-17
2019-12-20
MOORE ERIN
SVP, Finance
A - Grant
Stock Option (Right to Buy)
9,400
$0.00
1
$593.84M